These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine. Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773 [TBL] [Abstract][Full Text] [Related]
24. Biochemical modulation of iododeoxyuridine by N6-[4-(morpholinosulfonyl)benzyl]-N6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) leading to enhanced cytotoxicity. Pressacco J; Mitrovski B; Hedley DW; Tsang R; Erlichman C Biochem Pharmacol; 1995 Jun; 50(1):55-60. PubMed ID: 7605345 [TBL] [Abstract][Full Text] [Related]
25. Effects of resveratrol and methoxyamine on the radiosensitivity of iododeoxyuridine in U87MG glioblastoma cell line. Khoei S; Shoja M; Mostaar A; Faeghi F Exp Biol Med (Maywood); 2016 Jun; 241(11):1229-36. PubMed ID: 26748400 [TBL] [Abstract][Full Text] [Related]
26. Correlation between cell reproductive death and chromosome aberrations assessed by FISH for low and high doses of radiation and sensitization by iodo-deoxyuridine in human SW-1573 cells. Franken NA; Ruurs P; Ludwików G; van Bree C; Kipp JB; Darroudi F; Barendsen GW Int J Radiat Biol; 1999 Mar; 75(3):293-9. PubMed ID: 10203180 [TBL] [Abstract][Full Text] [Related]
27. The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure. Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1393-8. PubMed ID: 2370189 [TBL] [Abstract][Full Text] [Related]
28. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement. Epstein AH; Lebovics RS; Goffman T; Teague D; Fuetsch ES; Glatstein E; Okunieff P; Cook JA J Natl Cancer Inst; 1994 Dec; 86(23):1775-80. PubMed ID: 7966416 [TBL] [Abstract][Full Text] [Related]
29. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation. Greene RF; Collins JM Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128 [TBL] [Abstract][Full Text] [Related]
30. Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine. Fornace AJ; Dobson PP; Kinsella TJ Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):873-8. PubMed ID: 2323975 [TBL] [Abstract][Full Text] [Related]
31. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs. Kinsella TJ; Dobson PP; Mitchell JB; Fornace AJ Int J Radiat Oncol Biol Phys; 1987 May; 13(5):733-9. PubMed ID: 3570896 [TBL] [Abstract][Full Text] [Related]
33. Possible importance of PLD repair in the modulation of BrdUrd and IdUrd-mediated radiosensitization in plateau-phase C3H10T1/2 mouse embryo cells. Iliakis G; Wright E; Ngo FQ Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Mar; 51(3):541-8. PubMed ID: 3494702 [TBL] [Abstract][Full Text] [Related]
34. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells. Chi KH; Kunugi KA; Kinsella TJ Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100 [TBL] [Abstract][Full Text] [Related]
35. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine. Fischer PH; Weddle MA; Mossie RD Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913 [TBL] [Abstract][Full Text] [Related]
36. Optimal photon energies for IUdR K-edge radiosensitization with filtered x-ray and radioisotope sources. Karnas SJ; Yu E; McGarry RC; Battista JJ Phys Med Biol; 1999 Oct; 44(10):2537-49. PubMed ID: 10533927 [TBL] [Abstract][Full Text] [Related]
37. Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells. Van Bree C; Franken NA; Bakker PJ; Klomp-Tukker LJ; Barendsen GW; Kipp JB Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):489-96. PubMed ID: 9308955 [TBL] [Abstract][Full Text] [Related]
38. Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine. Miller EM; Fowler JF; Kinsella TJ Radiat Res; 1992 Jul; 131(1):81-9. PubMed ID: 1626052 [TBL] [Abstract][Full Text] [Related]
39. Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines. Benson AB; Trump DL; Cummings KB; Fischer PH Biochem Pharmacol; 1985 Nov; 34(21):3925-31. PubMed ID: 2933042 [TBL] [Abstract][Full Text] [Related]
40. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells. Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]